JNJ-41443532

DB12632InvestigationalSmall molecule

JNJ-41443532 has been used in trials studying the basic science and treatment of Diabetes Mellitus, Type 2.

Mechanism: Pharmacologically active on C-C chemokine receptor type 2
Curator reviewed
Formula / weight: C₂₂H₂₅F₃N₄O₃S · 482.52 g/mol (avg)
Code names: JNJ-41443532

Resolves to

Compound

Structure

InChIKeyCFKBNYUHQSQBSX-CYWCHRQTSA-NSMILESO[C@]1(CC[C@@H](CC1)N1CC(C1)NC(=O)CNC(=O)C1=CC=CC(=C1)C(F)(F)F)C1=CN=CS1

Targets

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with JNJ-41443532, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.